Trials / Completed
CompletedNCT02483299
Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary Syndrome
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- University Medical Centre Ljubljana · Academic / Other
- Sex
- Female
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to determine whether combined treatment with liraglutide and metformin is more effective than metformin as monotherapy in the treatment of obese women with polycystic ovary syndrome (PCOS). We anticipated greater changes in body weight in patients on combined treatment than in those on monotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metformin | |
| DRUG | Glucophage tablets and Victoza |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2015-04-01
- Completion
- 2015-04-01
- First posted
- 2015-06-26
- Last updated
- 2015-06-26
Locations
1 site across 1 country: Slovenia
Source: ClinicalTrials.gov record NCT02483299. Inclusion in this directory is not an endorsement.